BU-NOT-SET

CONTACT US
Why outsourcing is key to bringing flexibility and capacity to the manufacture of oral solid dosage forms
  • Manufacturing
Eyes
Insight
Can bigger be better?
  • Industry trends
Eyes
Insight
What does 2017 have in store for the pharma industry?
  • Industry trends
Eyes
Insight
Reflecting on 2017 | the factors shaping our industry
  • Industry trends
Eyes
Insight
Protecting against counterfeiting with serialisation
  • Manufacturing
Eyes
Insight
Manufacturing Chemist CDMO roundtable – part two
  • Industry trends
Eyes
Insight
Manufacturing Chemist CDMO roundtable – part one
  • Industry trends
Eyes
Insight
Increased drive to outsource manufacturing in life science
  • Industry trends
  • Manufacturing
Eyes
Insight
Serialisation: the final countdown
  • Manufacturing
Eyes
Insight
Insight
  • Industry trends
A CDMO’s insight into the pharma M&A landscape
Insight
  • Industry trends
Recipharm’s continuous global support throughout the COVID-19 pandemic
Insight
  • Manufacturing
Is outsourcing the most viable pathway for innovators?
Case study
  • Drug product
Developing a generic prolonged-release isosorbide-5-mononitrate tablet
Insight
  • Industry trends
Recipharm Wins two 2020 CMO Leadership Awards
Insight
  • Corporate
Recipharm’s global teams support and engage with their local communities in the fight against COVID-19
Insight
  • Manufacturing
Recipharm launches new virtual inspection and audit tool for customers, in light of COVID-19 outbreak
Brochure
  • Corporate
Recipharm 25 years
Fact sheet
  • Drug substance
API product list